By Karen Freifeld (Reuters) -A new version of a congressional bill that would restrict U.S. business with certain Chinese biotechnology…
Read More »Biotechs
Maria Vonotna November was a month to remember for biotech stocks as gene therapy developers outperformed and pharma giants looked…
Read More »monsitj JP Morgan said it was bullish on Insmed (NASDAQ:INSM), Denali (NASDAQ:DNLI), Immunocore (NASDAQ:IMCR), Crinetics (NASDAQ:CRNX), Mirum (NASDAQ:MIRM) and BioCryst…
Read More »